Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Cefixime

A third-generation cephalosporin taken by mouth, patented in 1979 and approved in the United States in 1989: it is used for urinary tract infections, ear infections, sore throat, tonsillitis and bronchitis. This family brings together the active ingredient, pharmacopoeial impurities, nitrosamines and other impurities.

Did you know?It is on the World Health Organization's List of Essential Medicines and, besides common infections, it is also used against typhoid fever.

CefiximeGo to the active ingredient →
CefiximeActive ingredientCefiximeCat. No. P-C084-001CAS 79350-37-1

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Reference substanceCefixime CRSEDQM code C0684000Family Cefixime

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.